Eli Lilly has agreed to take over ImClone for $70 a share in cash, valuing the cancer drug maker at about $6.5bn and trumping an unsolicited bid from Bristol-Myers.

http://us.ft.com/ftgateway/superpage.ft?news_id=fto100620081318074574&referrer_id=yahoofinance

BioAlliance Pharma SA : acts in favour of patients' quality of life in connection with the French national event 'La Semaine du GoÃ»t' (Marketwire)

News | biz.yahoo.com | 2 hours 15 minutes ago

BioAlliance Pharma SA : acts in favour of patients' quality of life in connection with the French national event 'La Semaine du Goût'. - PARIS--(MARKET WIRE)--Oct 6, 2008 -- BioAlliance Pharma SA (Euronext Paris, ISIN code: FR0010095596-BIO), the specialty pharmaceutical company focused on the

http://biz.yahoo.com/iw/081006/0440483.html

Bristol-Myers won't raise bid for ImClone (at MarketWatch)

News | www.marketwatch.com | 3 hours 14 minutes ago

BOSTON (MarketWatch) -- Bristol-Myers Squibb said Monday that it will not raise its $62 as share bid for ImClone Systems , in which it already holds a 16.6% stake, adding that raising the bid was not in the best interest of its shareholders. Earlier Monday, Eli Lilly & Co. announced that it plans

http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b7C81B37A-4BD6-47CB-A8B1-466673D2AD92%7d&siteid=yhoof2

Icahn Wins, But Bristol Isn't A Total Loser Either (at Forbes.com)

News | www.forbes.com | 4 hours 35 minutes ago

Carl Icahn sells ImClone to Eli Lilly for $7 a share more than Bristol was offering.

http://www.forbes.com/2008/10/06/imclone-icahn-lilly-biz-healthcare-cx_mh_1006imclone.html?partner=yahootix

Lilly to Acquire ImClone

News | www.contractpharma.com | 5 hours 15 minutes ago

Eli Lilly and Co. and ImClone Systems have entered a definitive merger agreement under which Lilly will acquire ImClone for approximately $6.5 billion in cash.

http://www.contractpharma.com/news/2008/10/06/lilly_to_acquire_imclone_

Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron(R) in Hepatitis C

News | www.biospace.com | 7 hours 3 minutes ago

PITTSBORO, NC--(MARKET WIRE)--Oct 6, 2008 -- Biolex Therapeutics, Inc. announced the closing of a $60 million Series D financing led by Clarus Ventures, a leading biotechnology investor, with OrbiMed Advisors participating as a new investor. Existing investors participating in the financing

http://www.biospace.com/news_story.aspx?StoryID=111949&full=1

Nobel prize for viral discoveries

News | news.bbc.co.uk | 9 hours 5 minutes ago

The discovery of HIV and work linking a virus to cervical cancer jointly win the Nobel Prize for Medicine.

http://news.bbc.co.uk/2/hi/health/7654214.stm

Irish Medical Times | News | No decline in errors in years

News | www.imt.ie | 9 hours 47 minutes ago

The frequency of errors in medical treatment in hospitals and medical practices, despite all the advances in technology and education, has not declined over the last 20 years, according to the President of the European Health Forum, Gastein, a body that helps to develop European healthcare policy.

http://www.imt.ie/news/2008/10/no_decline_in_errors_in_years.html

[$$] Roche Reduces Drug's Price To Get U.K. System on Board (at The Wall Street Journal Online)

News | online.wsj.com | 21 hours ago

LONDON -- Britain's state-run health service agreed to pay for the lung-cancer drug Tarceva, but only after the drug's maker, Roche Holding AG, agreed to match the price of an older, less-expensive drug.

http://online.wsj.com/article/SB122324392698405849.html?mod=yahoo_hs&ru=yahoo